Cellares

Private

South San Francisco-based first 'Integrated Development and Manufacturing Organization' (IDMO) for cell therapy. Delivered first GMP cell therapy doses to patients in April 2026. 10-year supply deal with Cabaletta Bio. Global Smart Factory network launching 2027. Founded April 2019.

Founders Fabian Gerlinghaus

CEO Fabian Gerlinghaus

Company

Founded

2019

Headquarters

South San Francisco, USA

Financials

Total Funding

$532M

Sectors

Healthtech Biotech Hardware

cellares.com

Funding History

3 rounds

Series D Jun 9, 2026

$20M

ARK Invest (Lead)

Series D Jan 15, 2026

$257M

BlackRock (Lead) Eclipse T. Rowe Price Investment Management Baillie Gifford Duquesne Family Office Intuitive Ventures EDBI Gates Frontier DC Global Ventures DFJ Growth Willett Advisors

Series C Aug 1, 2023

$255M

Koch Disruptive Technologies (Lead)

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.